Skip to content
Catalyst

methylphenidatePapers

Indexed under methylphenidate as a PubMed major topic

papers
198
17 years, by papers

Newest first

1 to 50 of 198

Every paper here, unless its row says otherwiseIndexed under methylphenidate in PubMed

  • The benefit of long-term methylphenidate in childhood brain injury survivorship: A review.

    Applied neuropsychology2026PMID 39401258

  • Methylphenidate (Ritalin) does not improve exam performance in an experimental setting.

    Psychopharmacology2026PMID 40762809

  • Change in vital parameters at first methylphenidate administration as a predictor of treatment response at six-month follow-up.

    European child & adolescent psychiatry2026PMID 40879766

  • Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET Study.

    Psychiatry and clinical neurosciences2026PMID 41128391

  • Use of methylphenidate and the risk of cardiovascular diseases in children and adolescents with a family history of heart diseases and congenital heart diseases: A self-controlled case series study.

    European child & adolescent psychiatry2026PMID 41182374

  • Methylphenidate for Depression in Advanced Cancer: Exploratory Meta-Analysis of Randomized Trials.

    Journal of pain and symptom management2026PMID 41290057

  • Practice Guideline for Methylphenidate Use in Persons With Traumatic Brain Injury: Report of the American Congress of Rehabilitation Medicine.

    Archives of physical medicine and rehabilitation2026PMID 41297654

  • ADHD and Methylphenidate Use in Prepubertal Children and BMI and Height at Adulthood.

    JAMA network open2026PMID 41490109

  • Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.

    Journal of clinical psychopharmacology2026PMID 41582768

  • Integrative Review of the Effects of Nonprescriptive Methylphenidate Use.

    Journal of clinical psychopharmacology2026PMID 41587052

  • Evaluating methylphenidate as a potential treatment for cocaine use disorder: a propensity score-matched study.

    The American journal of drug and alcohol abuse2026PMID 41701923

  • The Acute Effect of Methylphenidate Ingestion in a Visuomotor Task at Absolute Power Alpha in Healthy Subjects.

    Arquivos de neuro-psiquiatria2026PMID 41871623

  • The Effect of Methylphenidate Treatment on Oxidative Stress Levels in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Observational Study.

    Journal of child and adolescent psychopharmacology2026PMID 41873451

  • Methylphenidate Treatment and Risk of Psychotic Disorder.

    JAMA psychiatry2026PMID 41879751

  • Methylphenidate in improving cancer-related fatigue: efficacy and safety - systematic review and meta-analysis of randomised controlled trials with trial sequential analysis.

    BMJ supportive & palliative care2026PMID 41912283

  • The Effect of Combined Iron and Methylphenidate Use in Iron Deficient Attention deficit Hyperactivity Disorder (ADHD) Children of Bangladesh.

    Mymensingh medical journal2026PMID 41914113

  • Longitudinal and Seasonal Trends in Reimbursed and Non-Reimbursed Methylphenidate Dispense and Its Most Common Alternatives in Belgium.

    Pharmacoepidemiology and drug safety2026PMID 42003424

  • Comparative Cardiovascular Safety of Prescription Amphetamine and Methylphenidate Initiation Among Older Adult Medicare Beneficiaries.

    Pharmacoepidemiology and drug safety2026PMID 42003446

  • Methylphenidate and Psychotic Symptoms in Children and Adolescents: A Disproportionality Analysis on the WHO Safety Database (VigiBase).

    Journal of child and adolescent psychopharmacology2026PMID 42015492

  • Pharmacokinetics and safety study of methylphenidate hydrochloride sustained-release tablets in Chinese healthy participants.

    Journal of pharmaceutical sciences2026PMID 42055446

  • Psychiatric safety of methylphenidate in adults with major depressive disorder: a 1-year retrospective cohort study of 6,422 patients.

    Psychological medicine2026PMID 42083867

  • Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

    International clinical psychopharmacology2026PMID 42127382

  • Methylphenidate-Type Psychostimulants for Cancer-Related Fatigue: Updated Meta-Analysis of Randomized Controlled Trials.

    Journal of the National Comprehensive Cancer Network2026PMID 42140261

  • Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial.

    Alzheimer's research & therapy2026PMID 42178577

  • Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.

    European neuropsychopharmacology2026PMID 42208423

  • Real-World Analysis Comparing Persistence and Adherence of Delayed-Release/Extended-Release Methylphenidate with Stimulant Medications Among Patients with Attention-Deficit/Hyperactivity Disorder in the United States.

    Clinical therapeutics2026PMID 42218040

  • Investigation of the Effects of Methylphenidate on Hemodynamic Parameters in Children With ADHD.

    Pharmacology research & perspectives2026PMID 42243950

  • Clinical characteristics and outcomes of pediatric methylphenidate intoxication: a five-year single-center study.

    BMC pharmacology & toxicology2026PMID 42363304

  • A Randomised Open-Label Comparison of Dexamphetamine and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD): Symptom Response, Adherence and Weight Impact Over 12 Months.

    Journal of paediatrics and child health2026PMID 42415397

  • Selective enhancement of cost sensitivity by methylphenidate in adult ADHD: a randomized placebo-controlled trial.

    Psychological medicine2026PMID 42516082

  • Efficacy and tolerability of Methylphenidate in children and adolescents with ADHD : A Systematic Review.

    La Tunisie medicale2026PMID 42578778

  • Real-World Evidence on Short-Term Weight Changes Following Methylphenidate Use in Pediatric Population: A Retrospective Study Using Common Data Model.

    Clinical and translational science2026PMID 42634126

  • Lack of beneficial effect of planned treatment interruption in adults with ADHD treated with methylphenidate - clinical evidence.

    Psychiatry research2026PMID 42679659

  • Regulatory reform and adult methylphenidate dispensing in France: a nationwide interrupted time-series study.

    BMJ mental health2026PMID 42749337

  • Is methylphenidate truly cardiac-safe? Insight from biventricular speckle tracking echocardiography in pediatric patients with attention deficit hyperactivity disorder.

    European journal of pediatrics2026PMID 42754774

  • Treatment Trajectories of Methylphenidate versus Risperidone in Preschool ADHD: A 12-Week Retrospective Study.

    Turk psikiyatri dergisi2026PMID 42831355

  • Efficacy of Saffron as an Adjunct to Methylphenidate in Treating ADHD in Children Aged 6-12: A Randomized Clinical Trial.

    Brain and behavior2026PMID 42895808

  • Placebo-related improvement with methylphenidate treatment in children with ADHD.

    European child & adolescent psychiatry2025PMID 39126498

  • Methylphenidate differentially alters corticostriatal connectivity after traumatic brain injury.

    Brain2025PMID 39432756

  • Prediction of methylphenidate treatment response for ADHD using conventional and radiomics T1 and DTI features: Secondary analysis of a randomized clinical trial.

    NeuroImage. Clinical2025PMID 39591718

  • Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot study.

    European child & adolescent psychiatry2025PMID 39601808

  • Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy, Safety and Tolerability of Modified-Release Methylphenidate (MPH-MR) in Chinese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).

    CNS drugs2025PMID 39671144

  • Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records.

    BMC psychiatry2025PMID 39754122

  • Echocardiographic Evaluation of the Effect of Long-Term Methylphenidate Use on Cardiovascular Functions.

    Journal of attention disorders2025PMID 39754497

  • Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double-Blind, Placebo-Controlled Study.

    Human psychopharmacology2025PMID 39930713

  • Comparison of serious adverse effects of methylphenidate, atomoxetine and amphetamine in the treatment of ADHD: an adverse event analysis based on the FAERS database.

    BMC pharmacology & toxicology2025PMID 39980035

  • Methylphenidate and P300 in attention deficit hyperactivity disorder: A systematic review and meta-analysis.

    International journal of psychophysiology2025PMID 40064448

  • An examination of the ocular effects of methylphenidate used in children and adolescents diagnosed with attention-deficit hyperactivity disorder.

    International ophthalmology2025PMID 40085168

  • Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).

    International psychogeriatrics2025PMID 40086910

  • Methylphenidate Promotes a Frontoparietal-Dominant Brain State Improving Cognitive Performance: A Randomized Trial.

    The Journal of neuroscience2025PMID 40101961

The next 50 papers

Every paper about methylphenidate